Trial
NCT01732640
A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Vanderbilt-Ingram Cancer Center; National Comprehensive Cancer Network
Condition
Squamous Cell Carcinoma of the Head and Neck
Intervention
Afatinib
Why stopped
Slow accrual and high levels of toxicity lead to early termination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-26